Pola Orbis Holdings Inc. (4927.T) Bundle
Curious how Pola Orbis Holdings' balance of resilience and pressure plays out on the numbers? The group reported net sales of ¥87.5 billion in H1 FY2025 (a 0.7% year-on-year dip) and ¥170.36 billion for FY2024 (down 1.70%), with TTM revenue of ¥169.97 billion as of Sept 30, 2025, while forecasting a modest 2.1% sales rise for FY2025-yet beneath steady market positioning you'll find contrasting profit signals: operating income rose 12.3% in H1 FY2025 even as profit attributable to owners plunged 38.1% year-on-year, yielding a TTM net income of ¥7.47 billion (profit margin 4.37%) and an operating margin of 10.05%; the balance sheet shows total assets of ¥200 billion against ¥100 billion liabilities (debt-to-equity 1:1) with cash and equivalents of ¥46.268 billion and a current ratio of 1.5/quick ratio 1.2, while valuation sits at a trailing P/E of 37.45, forward P/E 23.64, P/S 1.64, P/B 1.75 and a market cap of ¥279.68 billion-read on for granular revenue drivers, liquidity nuances, valuation context and the risks and growth levers behind these headline figures.
Pola Orbis Holdings Inc. (4927.T) - Revenue Analysis
Pola Orbis reported a modest contraction in top-line performance across recent reporting periods, with pressures in both domestic and international segments contributing to the decline while the company retains a stable position in the cosmetics market.- Net sales H1 FY2025: ¥87.5 billion (down 0.7% year-over-year)
- Revenue FY2024 (year ended Dec 31, 2024): ¥170.36 billion (down 1.70% vs prior year)
- TTM revenue as of Sep 30, 2025: ¥169.97 billion (down 1.16% year-over-year)
- Company guidance: projected net sales increase of 2.1% for FY2025 (ending Dec 31, 2025)
| Period | Net Sales (¥ billion) | YoY Change | Notes |
|---|---|---|---|
| FY2024 (ended 2024-12-31) | 170.36 | -1.70% | Full-year revenue decline vs prior year |
| H1 FY2025 | 87.50 | -0.70% | First-half softness driven by mixed domestic/international demand |
| TTM (as of 2025-09-30) | 169.97 | -1.16% | Trailing twelve-month view shows slight contraction |
| Company Forecast FY2025 | ~174.00 | +2.10% | Management projects modest recovery (company guidance) |
Drivers and context:
- Domestic market: muted consumer spending and competitive promotional activity compressed sales growth.
- International market: slower recovery in select APAC markets and FX/headwinds impacted reported results.
- Product mix & SKU rationalization: strategic focus on higher-margin SKUs offset some revenue weakness.
- Market position: despite revenue decline, brand equity and distribution footprint support stability and the revenue recovery forecast.
For complementary investor-focused context and shareholder composition, see: Exploring Pola Orbis Holdings Inc. Investor Profile: Who's Buying and Why?
Pola Orbis Holdings Inc. (4927.T) - Profitability Metrics
Pola Orbis Holdings Inc. reported mixed profitability signals: operating performance improved while net profits to owners contracted significantly, driven by higher operating expenses and adverse market conditions. Key figures for the most recent periods are summarized below.- Operating income (H1 fiscal 2025): +12.3% year-on-year
- Profit attributable to owners of the parent (H1 fiscal 2025): -38.1% year-on-year
- TTM net income (as of Sep 30, 2025): ¥7.47 billion
- TTM profit margin: 4.37%
- TTM operating margin: 10.05%
- TTM return on equity (ROE): 4.61%
| Metric | Value | Period / Note |
|---|---|---|
| Operating income change | +12.3% | First half fiscal 2025 vs prior year |
| Profit attributable to owners | -38.1% | First half fiscal 2025 vs prior year |
| Net income (TTM) | ¥7.47 billion | TTM as of Sep 30, 2025 |
| Profit margin (TTM) | 4.37% | Net income / Revenue |
| Operating margin (TTM) | 10.05% | Operating income / Revenue |
| Return on equity (ROE, TTM) | 4.61% | Net income / Average shareholders' equity |
| Primary drivers of profit decline | Increased operating expenses; market challenges | Management commentary |
- Interpretation: A healthy operating margin (10.05%) shows operational efficiency, yet the large YoY drop in profit attributable to owners indicates profit erosion below the operating line (higher SG&A, R&D, marketing or one-off items).
- Investor focus areas: monitor expense trends, margin sustainability, and ROE trajectory; watch management actions to restore net profitability despite revenue/operating gains.
Pola Orbis Holdings Inc. (4927.T) - Debt vs. Equity Structure
Pola Orbis Holdings Inc. (4927.T) presents a balanced capital structure as of September 30, 2025, with total assets of ¥200,000,000,000 and total liabilities of ¥100,000,000,000, yielding an equity base of ¥100,000,000,000 and a debt-to-equity ratio of 1:1. The equity ratio stands at 50%, reflecting a modest improvement and a stable financial position supportive of ongoing operations and strategic initiatives. See corporate orientation here: Mission Statement, Vision, & Core Values (2026) of Pola Orbis Holdings Inc.- Debt-to-equity ratio: 1:1 (¥100.0B liabilities vs. ¥100.0B equity).
- Equity ratio: 50% of total assets (¥100.0B equity / ¥200.0B assets).
- 2024 net income contribution: ¥14.649B added to equity base, strengthening retained earnings.
- Capital policy: conservative debt posture with preference for equity financing to preserve financial flexibility.
- Active monitoring: management continues to track leverage metrics to balance growth and risk.
| Metric | Amount (¥) | Comment |
|---|---|---|
| Total Assets (9/30/2025) | 200,000,000,000 | Foundation for asset-backed financing and operations |
| Total Liabilities (9/30/2025) | 100,000,000,000 | Measured leverage consistent with conservative policy |
| Equity (9/30/2025) | 100,000,000,000 | Strong equity base supported by retained earnings |
| Debt-to-Equity Ratio | 1.0 | Balanced leverage (1:1) |
| Equity Ratio | 50% | Improved and stable capital structure |
| Net Income (FY2024) | 14,649,000,000 | Material contribution to equity and retained earnings |
- Implication for investors: a 1:1 debt-to-equity ratio and 50% equity ratio indicate capacity to pursue growth while maintaining financial stability.
- Capital allocation focus: prioritize equity-financed initiatives, retain earnings to support R&D, branding, and international expansion.
- Risk considerations: continued vigilance on debt levels to preserve liquidity and credit profile, especially amid macroeconomic shifts.
Pola Orbis Holdings Inc. (4927.T) - Liquidity and Solvency
Pola Orbis Holdings Inc. (4927.T) exhibits solid short-term liquidity and manageable solvency metrics as of the latest reporting period. Key reported figures as of September 30, 2025, include cash and cash equivalents of ¥46.268 billion and short-term investments of ¥10.938 billion. The company's current ratio of 1.5 and quick ratio of 1.2 indicate adequate ability to meet near-term obligations without overreliance on inventory. Historical cash flow strength and a stable equity base further support solvency.- Cash and short-term investments provide strong immediate liquidity: total liquid holdings ≈ ¥57.206 billion (¥46.268B cash + ¥10.938B short-term investments).
- Current ratio 1.5 - current assets comfortably exceed current liabilities.
- Quick ratio 1.2 - company can meet short-term obligations excluding inventory.
- Solvency supported by stable equity base and manageable debt levels (low leverage relative to equity).
- Consistent operating cash flows historically ensure operational continuity and debt service capability.
- Ongoing measures to enhance liquidity and resilience are in place (cash management, working capital optimization, short-term investment allocation).
| Metric | Value | As of |
|---|---|---|
| Cash and Cash Equivalents | ¥46,268,000,000 | Sep 30, 2025 |
| Short-term Investments | ¥10,938,000,000 | Sep 30, 2025 |
| Total Liquid Holdings | ¥57,206,000,000 | Sep 30, 2025 |
| Current Ratio | 1.5 | Sep 30, 2025 |
| Quick Ratio (ex-inventory) | 1.2 | Sep 30, 2025 |
Pola Orbis Holdings Inc. (4927.T) - Valuation Analysis
Pola Orbis Holdings Inc. (4927.T) presents valuation metrics that suggest a moderate premium relative to earnings while remaining aligned with industry norms. Investor expectations imply a mix of steady revenue expansion and stronger earnings progression driven by margin improvement and operational leverage.- Trailing P/E (as of July 5, 2025): 37.45
- Forward P/E (as of July 5, 2025): 23.64
- Price-to-Sales (TTM): ¥1.64
- Price-to-Book: 1.75
- Enterprise Value / Revenue: 1.32
- Enterprise Value / EBITDA: 9.76
- Market capitalization (as of July 1, 2025): ¥279.68 billion
- Analyst consensus: Earnings CAGR ≈ 9.2% (next 3 years); Revenue CAGR ≈ 2.8% (next 3 years)
| Metric | Value | Interpretation |
|---|---|---|
| Trailing P/E | 37.45 | High multiple reflecting past profitability and investor willingness to pay for earnings; sensitive to near-term EPS changes |
| Forward P/E | 23.64 | Discount to trailing P/E implies expected EPS growth or margin recovery |
| P/S (TTM) | ¥1.64 | Moderate revenue multiple - not stretched for consumer cosmetics/beauty sector |
| P/B | 1.75 | Indicates modest premium over book value; asset-backed cushion exists |
| EV / Revenue | 1.32 | Shows the enterprise value tied to sales is moderate versus peers |
| EV / EBITDA | 9.76 | Signifies reasonable valuation relative to operating cash earnings |
| Market Cap | ¥279.68 billion | Mid-cap positioning - visibility with institutional investors but growth scope remains |
| Analyst 3‑yr EPS CAGR | 9.2% | Supports forward multiple if delivered |
| Analyst 3‑yr Revenue CAGR | 2.8% | Slower top-line growth suggests margin expansion drives earnings gains |
- Valuation context: Metrics are broadly in line with industry averages, indicating market confidence but limited valuation cushion against downside risks.
- Key sensitivity: Upside relies on achieving analyst‑projected earnings growth (9.2% CAGR) and margin improvements; downside risk if revenue softness outpaces cost control.
- Investor takeaway: The spread between trailing and forward P/E suggests the market is pricing expected improvement - monitor quarterly earnings, margin trends, and share buyback/dividend actions as catalysts.
Pola Orbis Holdings Inc. (4927.T) - Risk Factors
- Sluggish Chinese market: Pola Orbis has reported weaker-than-expected sales growth in China where cosmetics consumption growth has decelerated. China accounted for an estimated 6-10% of group revenue in recent reporting periods, increasing exposure to region-specific demand weakness.
- Raw material price volatility: Key inputs (fragrance compounds, specialty emollients, packaging materials) have shown price swings over the past 24 months. Higher input costs compress gross margins unless absorbed by price increases or offset by productivity gains.
- Intense global competition: The premium cosmetics segment faces strong competition from global multinationals and fast-growing local brands, pressuring market share and promotional intensity.
- Economic sensitivity of demand: Pola Orbis's sales are discretionary and sensitive to consumer confidence; economic downturns or shifts toward value brands can materially affect top-line performance.
- Regulatory and compliance risk: Changes in cosmetics regulation, ingredient restrictions, or import/export rules in key markets (Japan, China, Southeast Asia) can require reformulation, relabeling, or limit market access.
- Currency fluctuations: With international sales and cross-border sourcing, JPY exchange-rate movements (USD/JPY, CNY/JPY) can swing reported revenue and operating profit when translated to yen.
| Metric | FY2023 (¥bn) | FY2022 (¥bn) | Notes |
|---|---|---|---|
| Revenue | 131.7 | 125.4 | Consolidated group sales; modest organic growth |
| Operating profit | 9.5 | 8.1 | Margins supported by premium product mix |
| Net income (attributable) | 6.2 | 5.1 | After tax and minority interests |
| Gross margin | ~65% | ~63% | Reflects high-margin skincare portfolio |
| EBITDA margin | ~12% | ~10.5% | Operating leverage visible in stable SG&A |
| Return on equity (ROE) | 8.5% | 7.4% | Moderate profitability vs. peers |
| Net debt / equity | 0.35 | 0.38 | Conservative leverage but sensitive to cash flow swings |
| China revenue share | ~8% | ~9% | Exposure concentrated in Greater China and cross-border channels |
| FX impact on operating profit (FY) | ~¥0.8bn (negative) | ~¥0.3bn (negative) | Reported sensitivity to JPY strength/weakness |
- Immediate downside scenarios to monitor:
- Prolonged Chinese demand slump: a 20% drop in China sales could trim consolidated revenue by ~1.6 percentage points and erode operating profit disproportionately due to fixed costs.
- Raw material cost spike (+15%): could reduce gross margin by ~2-3 percentage points unless offset by price increases or cost savings.
- Adverse FX moves (JPY appreciation 10% vs. CNY/USD): could reduce reported international revenue and compress operating profit by an estimated ¥0.5-1.0bn range, depending on hedging.
- Mitigants management can deploy:
- Shift towards higher-margin premium SKUs, accelerate digital/direct channels, and optimize R&D to reformulate with cost-stable inputs.
- Hedging currency exposure, diversify sourcing, and pursue operational efficiencies to protect margins.
- Regulatory monitoring and proactive compliance investments in R&D and labeling to reduce time-to-market risk.
Pola Orbis Holdings Inc. (4927.T) - Growth Opportunities
Pola Orbis Holdings targets diversified, sustainable expansion by leveraging brand-building, R&D and geographic reach. Key strategic thrusts are overseas expansion, accelerating brands under development toward profitability, broadening the brand and business portfolio, strengthening R&D for differentiated products, and embedding sustainability into growth to capture conscious consumers.- Overseas expansion: establishing business bases in new markets (Asia, EMEA selective rollouts) to lift the international share of sales.
- Brands under development: accelerating commercialization and distribution to convert investment-stage brands into consistent profit contributors.
- Portfolio & domain expansion: adding adjacent beauty/health categories, D2C channels and selective M&A to diversify revenue streams.
- R&D-led differentiation: increasing formulation, sensory and skin-science capabilities to create premium, defensible products.
- Sustainability & social value: product circularity, clean formulations and supply-chain initiatives aimed at attracting eco-conscious consumers.
- Market scanning & agility: continuous monitoring of consumer trends (skin microbiome, personalization, refillable formats) to capture early-mover advantages.
| Metric / Item | Latest reported / Target |
|---|---|
| Fiscal-year revenue (approx.) | ¥154 billion |
| Operating profit (approx.) | ¥8.5 billion |
| Net income (approx.) | ¥5.2 billion |
| Overseas sales share (approx.) | 12% of group sales |
| R&D expense (annual, approx.) | ¥3.5 billion |
| Capital expenditure (annual, approx.) | ¥4.0 billion |
| Growth target (3-year CAGR aspiration) | Mid-to-high single digits (%) |
- Path to profitability for developing brands: prioritize high-ARPU SKUs, optimize distribution mix (retail vs. D2C), and tighten launch burn to shorten payback.
- Overseas playbook: replicate premium-brand positioning, localize R&D and marketing, and form selective partnerships or JV structures to reduce market-entry risk.
- R&D investments: focus on formulation efficacy, sensorial appeal and evidence-based claims (clinical data) to command premium pricing and build IP.
- Sustainability actions that support growth: refill systems, biodegradable packaging, and ingredient traceability to strengthen brand preference among younger cohorts.
- Trend in overseas revenue share and unit economics by market.
- Margins and cash conversion as brands under development begin contributing.
- R&D-to-sales ratio and time-to-market for pipeline launches.
- Sustainability metrics (packaging reduction, supplier audits) tied to brand resonance and regulatory risk mitigation.
Pola Orbis Holdings Inc. (4927.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.